Medical Breakthrough Prediction
In reading Technology’s
Promise, by William E. Halal, I found the most interesting technological
predictions to be centered on medical advances. This is because this industry
is one of the most important topics to all of humans around the global. Without
accurate healthcare, our live expectancy is endangered. One of the predictions
identified in the book centered on genetic therapy.
As stated by Halal, “One of the
greatest lures of biotech is eliminating the 5,000 genetic diseases that plague
humankind. Progress is slow, but results are likely about 2024 (2008).”
Forces that could
affect effectiveness:
1. Legal (Global) -This alternative is still deemed a
“risky” procedure and must obtain special U.S. Food and Drug Administration
(FDA) privileges in order for research to be conducted. At any given time, the
FDA may reject or suspend the clinical trials if the safety of the participants
is suspected. These types of laws vary from country and may yield some
unforeseen hurdles for global treatment adoptions. The National Institutes of
Health (NIH) has an important role in ensuring the safety of gene therapy
research (U.S. National Library of Medicine, 2012). An Institutional Review Board (IRB) and an
Institutional Biosafety Committee (IBC) must approve each gene therapy clinical
trial before it can be carried out (U.S. National Library of Medicine, 2012).
2. Financial – This treatment is still in the early stages
of its development there for the technology that is needed may be somewhat of a
costly challenge for families which may be on the poverty borderline. Often
these are the high population of patients in which contract incurable disease
most useful for the gene therapy procedures.
3. Ethical – This procedure affects the body’s genetic
makeup and may people have concerns and questions regarding the use of gene
therapy in the development of a fetus that may have long-term side effects.
Also if the parent chooses to undergo the treatment it is given to the child as
well due to the transference of gene makeup not allowing the child once it is
older to be given a choice as to whether or not he would have chosen to undergo
the treatment (U.S. National Library of Medicine, 2012).
4. Technical – This is a factor because the treatment must
be applied to specific genes and thru the current injection procedure this has
been proven to be somewhat a challenge (U.S. National Library of Medicine,
2012).
References:
Halal, W. (2008).
Technology's promise: Expert knowledge on the transformation of business and
society. Houndmills, Basingstoke, Hampshire England New York: Palgrave
Macmillan.
U.S. National
Library of Medicine. (2012 Sept 03). Gene
therapy. Retrieved from: http://ghr.nlm.nih.gov/handbook/therapy